Iambic Therapeutics Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IAM and other ETFs, options, and stocks.

About IAM

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. 

CEO
Thomas Miller
CEOThomas Miller
Employees
—
Employees—
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2019
Founded2019
Employees
—
Employees—

IAM Key Statistics

Market cap
758.41M
Market cap758.41M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
—
52 Week high—
52 Week low
—
52 Week low—

Stock Snapshot

As of today, Iambic Therapeutics Inc.(IAM) shares are valued at $16.00. The company's market cap stands at 758.41M.

On 2026-10-15, Iambic Therapeutics Inc.(IAM) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Iambic Therapeutics Inc.(IAM) stock has reached 0.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.